Clinical Trial Software Market Size to Reach USD 2,862.0 Million in 2028 Growing at a CAGR of 15.6%, according to Emergen Research
Emergen Research has published its latest report titled “Clinical Trial Software Market, By Deployment (Cloud, On-premises), By Delivery Model (Web-based, Licensed Enterprise, Software as a Service), By End-use (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Medical Device Manufacturers, Others), and By Region, Forecast to 2028”
According to Emergen Research, the global clinical trial software market size was USD 900.3 Million in 2020 and is expected to reach USD 2,862.0 Million in 2028 and register a revenue CAGR of 15.6% during the forecast period, 2021-2028.
The global clinical trial software market revenue growth has registered significant revenue growth over the recent past due to factors such as rising burden of chronic and infectious diseases worldwide, growing targeted patient population, increasing need for development of new drugs and therapeutics, and rapid adoption of clinical trial management software and solutions to streamline clinical trial processes and workflow. Rising adoption of AI and cloud-based technologies, advanced biometric devices, cutting-edge data analytics, and connected devices and wearables has streamlined and improved clinical trial processes significantly.
Pharmaceutical and biotechnology companies and CROs need clinical trial management solutions to improve the safety and efficacy of clinical trial processes, facilitate patient recruitment and retention, streamline financial management, and ensure regulatory compliances are met. Hence, rising focus of life sciences companies on conducting decentralized or virtual clinical trials to enable real-time patient monitoring, accelerate clinical development timelines, and reduce financial burdens is a major factor driving the global market revenue growth.
COVID-19 Impact Analysis:
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Web-based Delivery Model Segment Accounted for Largest Revenue Share in 2020:
The web-based segment held the largest revenue share in the global market in 2020, owing to factors such as increasing preference for web-based clinical trial software and solutions due to advantages such as cost-efficiency, improved productivity, and easy accessibility. Web-based clinical trial solutions enable faster deployment of protocols, reduce clinical trial life cycle, provide easy access to web-interfaces, and help save on R&D costs and time.
Pharmaceutical & Biotechnology Companies Segment to Account for Fastest Revenue CAGR:
The pharmaceutical & biotechnology companies segment is projected to register the fastest revenue CAGR over the forecast period. Rising focus on development of new drugs and therapeutics, growing adoption of advanced clinical trial management solutions to streamline and automate clinical research and trials, and increasing need for clinical trial management software for clinical trial disclosure and risk-based monitoring are expected to drive this segment’s growth.
North America Accounted for Largest Revenue Share in 2020:
North America clinical trial software market dominated other regions in terms of revenue share contribution in the global market in 2020. Rise in geriatric population, growing prevalence of chronic and infectious diseases, increasing R&D new drug development, and increasing focus on conducting virtual clinical trials are key factors boosting revenue growth of the North America market. Increasing adoption of cloud-based and SaaS-based clinical trial management solutions, rising government investments in the pharmaceutical and biotechnology sectors, and presence of key market players such as Johnson & Johnson, Pfizer Inc., Oracle Corporation, and Bristol Myers Squibb further drive the regional market revenue growth.
Make Payment [Buy your Exclusive copy]@ https://www.emergenresearch.com/select-license/766
Major Companies in the Global Clinical Trial Software Market Include:
- Johnson & Johnson
- Pfizer Inc.
- Merck & Co., Inc.
- GlaxoSmithKline Plc
- Novo Nordisk A/S
- Amgen Inc.
- Bristol Myers Squibb
- Novartis International AG
- Medidata Solutions Inc.
- International Machine Business Corporation (IBM)
- Oracle Corporation
- Parexel International Corp.
- RealTime Software Solutions LLC
- BioClinica Inc.
- MasterControl Inc.
- MedNet Solutions Inc.
- Veeva Systems Inc.
- ArisGlobal LLC
For the purpose of this report, Emergen Research has segmented the global clinical trial software market based on deployment, delivery model, end-use, and region:
Deployment Outlook (Revenue, USD Million; 2018–2028)
Delivery Model Outlook (Revenue, USD Million; 2018–2028)
- Licensed Enterprise (On-premise)
- Software-as-a-Service (SAAS)
End-use Outlook (Revenue, USD Million; 2018–2028)
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations (CROs)
- Medical Device Manufacturers
Region Outlook (Revenue, USD Million; 2018-2028)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Automotive data monetization market size is expected to reach USD 86.91 Billion in 2028 and register a CAGR of 38.5% during the forecast period. Global automotive data monetization market revenue growth is driven by key factors such as increased and advanced analytics and big data in automotive applications to additional features and services in cars, reduce operational costs and investment, and enhance driver and passenger safety.
Battery monitoring system market size reached USD 3.64 Billion in 2020, and is expected to register a CAGR of 17.8% during the forecast period. Rising fuel prices and rapid trend of attaining zero-emission levels are factors also contributing to rising demand for electric vehicles and lithium-ion based batteries as a result.
Advanced Driver Assistance System (ADAS) market size is expected to reach USD 66.14 Billion in 2028 and register a CAGR of 11.8% during the forecast period. Advanced driver assistance system market revenue growth is driven by rise in demand for safety features in vehicles, implementation of stringent safety regulations, and technological advancements in ADAS.
Head-up display market size is expected to reach USD 9.72 Billion in 2028 and register a CAGR of 28.4% during the forecast period. Some key factors driving market revenue growth are rising spending capacity, resulting is rising demand for personal vehicles, and in turn driving a rapid incline in the number of vehicles on the road.
Electric vehicle fluids and lubricants market size was USD 1,178.8 Million in 2020 and is expected to register a CAGR of 18.7% during the forecast period. Increasing demand for effective and reliable electric vehicle fluids is expected to drive the global electric vehicle fluids and lubricants market growth over the forecast period.
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756